Development of an optimal imaging strategy for selection of patients for affibody-based PNA-mediated radionuclide therapy

Affibody molecules are engineered scaffold proteins, which demonstrated excellent binding to selected tumor-associated molecular abnormalities in vivo and highly sensitive and specific radionuclide imaging of Her2-expressing tumors in clinics. Recently, we have shown that peptide nucleic acid (PNA)-...

Descripción completa

Detalles Bibliográficos
Autores principales: Vorobyeva, Anzhelika, Westerlund, Kristina, Mitran, Bogdan, Altai, Mohamed, Rinne, Sara, Sörensen, Jens, Orlova, Anna, Tolmachev, Vladimir, Karlström, Amelie Eriksson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018533/
https://www.ncbi.nlm.nih.gov/pubmed/29942011
http://dx.doi.org/10.1038/s41598-018-27886-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018533/
https://www.ncbi.nlm.nih.gov/pubmed/29942011
http://dx.doi.org/10.1038/s41598-018-27886-0

Ejemplares similares